Welcome to the Phagenesis LinkedIn page! 

At Phagenesis, we are dedicated to transforming the way dysphagia is treated.Dysphagia, or difficulty swallowing, can be a debilitating condition that affects millions of people worldwide. 

We believe that everyone deserves the ability to enjoy their meals and live their lives to the fullest, which is whywe have developed the Phagenyx - a revolutionary product that uses pharyngeal electrical stimulation (PES) to treat dysphagia. 

The Phagenyx is a simple, non-invasive device that stimulates the nerves in the pharynx, helping patients regain control of their swallowing function. Our product has been rigorously tested in clinical trials and has been shown to significantly improve swallowing ability in patients with dysphagia. 

As a company, we are committed to advancing the field of dysphagia care through innovative technology and evidence-based practices. We work closely with healthcare providers and patients to ensure that our product meets the highest standards of safety and efficacy. 

We are proud to be changing the paradigm of dysphagia care, and we invite you to join us in our mission to improve the lives of millions of people around the world. Follow our page to stay up-to-date on the latest news and developments in dysphagia care, and to learn more about the Phagenyx and how it is helping patients overcome dysphagia.

MedTech Innovator

Inventages Venture Capital Investment Inc.

Phagenesis Ltd

We'll be at #ISC2024 this week in Phoenix, AZ! Dr. Andrei Alexandrov will be sharing observations from the first US patient experiences with the #Phagenyx #Neurostimulation System. Attend his presentation and drop by the booth to learn how Phagenyx can help #stroke #patients  who struggle to swallow. 

Scott Grant
Alyssa Cook
Reinhard Krickl

#justgettingstarted #PES #icu #criticalcare 

#thankyou to the PhEAST Clinical Trial Project Management team for hosting an incredible day of education and training in Nottingham, UK. It really takes a village to execute a clinical trial at the highest level and we couldn’t be more proud to partner with a team like this!

Learn more about the PhEAST trial here - https://lnkd.in/gQnG93Te

#teamworkmakesthedreamwork #phagenyx #pheast #PES #criticalcare #ICU #dysphagia

Another incredible patient story from Banner Health and University of Arizona College of Medicine - Phoenix. Jeremy Hogue, the former University of Southern California #Football  Academic All-American Center suffered a stroke, affecting his speech, the right side of his body and how well he could swallow. 

Under Chief of Neurology Dr. Andrei Alexandrov and the medical and speech-language pathology team at Banner, Jeremy received #neurostimulation treatment with #Phagenyx to restore swallowing control. 

“It’s validating, that’s how I’m feeling. It’s pretty cool to say that I’ve been doing this almost six months and in six days I finally have dramatic improvement."

#believe #teamworkmakesthedreamwork #trojans 

Phagenesis Limited is a company that provides a privacy policy for its website, www.phagenesis.com. The company does not collect personal data from users unless they contact them through the contact form.

COM:PHAGENESIS

Phagenesis Limited

Filings Not Available